Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Biochem. 2013 Oct;46(15):1474-7. doi: 10.1016/j.clinbiochem.2013.04.009. Epub 2013 Apr 20.

Clinical significance of serum mitochondrial DNA in lung cancer.

Author information

  • 1Clinical Laboratories, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.

Abstract

OBJECTIVES:

The aim of the study was to investigate the clinical significance of serum mitochondrial DNA (mtDNA) in lung cancer.

DESIGN AND METHODS:

Serum mtDNA from 65 lung cancer patients, 20 patients with benign lung diseases and 55 healthy individuals was quantified using real-time fluorescent quantitative polymerase chain reaction (FQ-PCR). Data were analyzed using statistical software SPSS 13.0.

RESULTS:

Serum mtDNA levels in lung cancer patients were significantly higher, compared to those in patients with benign lung diseases and healthy individuals (u=108, p=0.000; u=293, p=0.000), and closely associated with TNM stage (p=0.01). The use of serum mtDNA facilitated detection of lung cancer at a cutoff value of 0.74×10⁴ copies/μL with a sensitivity of 86.2% and specificity of 80.7%. However, serum mtDNA levels were not associated with patient age, gender, histological type, and lymph node metastasis (p>0.05).

CONCLUSIONS:

Quantification of serum mtDNA using FQ-PCR potentially serves as a novel complementary tool to improve the clinical screening and detection of lung cancer.

Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

KEYWORDS:

Diagnostic efficacy; Lung cancer; Serum mitochondrial DNA

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk